Annual SGA
$5.03 M
-$1.01 M-16.73%
December 31, 2023
Summary
- As of February 7, 2025, PBLA annual SGA is $5.03 million, with the most recent change of -$1.01 million (-16.73%) on December 31, 2023.
- During the last 3 years, PBLA annual SGA has risen by +$1.78 million (+54.91%).
- PBLA annual SGA is now -16.73% below its all-time high of $6.04 million, reached on December 31, 2022.
Performance
PBLA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.11 M
+$7000.00+0.63%
September 30, 2024
Summary
- As of February 7, 2025, PBLA quarterly SGA is $1.11 million, with the most recent change of +$7000.00 (+0.63%) on September 30, 2024.
- Over the past year, PBLA quarterly SGA has increased by +$182.00 thousand (+19.55%).
- PBLA quarterly SGA is now -38.03% below its all-time high of $1.80 million, reached on March 31, 2022.
Performance
PBLA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$544.81 M
-$37.05 M-7.30%
September 30, 2024
Summary
- As of February 7, 2025, PBLA TTM SGA is -$544.81 million, with the most recent change of -$37.05 million (-7.30%) on September 30, 2024.
- Over the past year, PBLA TTM SGA has dropped by -$549.84 million (-10924.70%).
- PBLA TTM SGA is now -3885.42% below its all-time high of -$13.67 million.
Performance
PBLA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
PBLA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.7% | +19.6% | -10000.0% |
| 3 y3 years | +54.9% | -17.7% | -9830.4% |
| 5 y5 years | +138.8% | -17.7% | -9830.4% |
PBLA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.7% | +9.7% | -38.0% | +19.6% | -162.5% | at low |
| 5 y | 5-year | -16.7% | +155.1% | -38.0% | +137.8% | -246.8% | at low |
| alltime | all time | -16.7% | +1883.8% | -38.0% | +2682.5% | -3885.4% | at low |
Panbela Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.11 M(+0.6%) | $4.35 M(+0.1%) |
| Jun 2024 | - | $1.11 M(-8.1%) | $4.35 M(-11.0%) |
| Mar 2024 | - | $1.20 M(+29.3%) | $4.88 M(-2.9%) |
| Dec 2023 | $5.03 M(-16.7%) | $931.00 K(-15.9%) | $5.03 M(-13.2%) |
| Sep 2023 | - | $1.11 M(-32.6%) | $5.80 M(-3.1%) |
| Jun 2023 | - | $1.64 M(+21.5%) | $5.98 M(+6.9%) |
| Mar 2023 | - | $1.35 M(-20.2%) | $5.60 M(-7.3%) |
| Dec 2022 | $6.04 M(+31.8%) | $1.70 M(+31.0%) | $6.04 M(+7.5%) |
| Sep 2022 | - | $1.29 M(+2.9%) | $5.62 M(+7.0%) |
| Jun 2022 | - | $1.26 M(-30.0%) | $5.25 M(+0.3%) |
| Mar 2022 | - | $1.80 M(+41.3%) | $5.23 M(+14.1%) |
| Dec 2021 | $4.59 M(+41.2%) | $1.27 M(+37.6%) | $4.58 M(+8.8%) |
| Sep 2021 | - | $924.00 K(-25.5%) | $4.21 M(-6.6%) |
| Jun 2021 | - | $1.24 M(+8.0%) | $4.51 M(+14.5%) |
| Mar 2021 | - | $1.15 M(+27.5%) | $3.94 M(+20.9%) |
| Dec 2020 | $3.25 M(+64.7%) | $901.00 K(-26.3%) | $3.26 M(+15.3%) |
| Sep 2020 | - | $1.22 M(+82.5%) | $2.83 M(+27.0%) |
| Jun 2020 | - | $670.00 K(+43.2%) | $2.23 M(+4.2%) |
| Mar 2020 | - | $468.00 K(0.0%) | $2.14 M(+8.4%) |
| Dec 2019 | $1.97 M(-6.4%) | $468.00 K(-24.8%) | $1.97 M(+7.6%) |
| Sep 2019 | - | $622.00 K(+7.2%) | $1.83 M(+9.2%) |
| Jun 2019 | - | $580.00 K(+91.4%) | $1.68 M(-4.2%) |
| Mar 2019 | - | $303.00 K(-7.9%) | $1.75 M(-16.8%) |
| Dec 2018 | $2.11 M | $329.00 K(-29.6%) | $2.11 M(-28.5%) |
| Sep 2018 | - | $467.00 K(-28.6%) | $2.95 M(-1.6%) |
| Jun 2018 | - | $654.00 K(-0.6%) | $3.00 M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $658.00 K(-43.8%) | $2.83 M(-17.3%) |
| Dec 2017 | $3.42 M(+28.5%) | $1.17 M(+127.4%) | $3.42 M(-2.7%) |
| Sep 2017 | - | $515.00 K(+5.7%) | $3.52 M(+0.5%) |
| Jun 2017 | - | $487.00 K(-61.0%) | $3.50 M(+2.0%) |
| Mar 2017 | - | $1.25 M(-1.2%) | $3.43 M(+28.9%) |
| Dec 2016 | $2.66 M(+2.8%) | $1.26 M(+153.5%) | $2.66 M(+50.8%) |
| Sep 2016 | - | $499.00 K(+19.1%) | $1.77 M(+4.1%) |
| Jun 2016 | - | $419.00 K(-12.9%) | $1.70 M(-8.9%) |
| Mar 2016 | - | $481.00 K(+30.7%) | $1.86 M(-27.7%) |
| Dec 2015 | $2.59 M(+115.8%) | $368.00 K(-14.2%) | $2.58 M(+0.2%) |
| Sep 2015 | - | $429.00 K(-26.7%) | $2.57 M(+4.2%) |
| Jun 2015 | - | $585.00 K(-51.1%) | $2.47 M(+18.2%) |
| Mar 2015 | - | $1.20 M(+229.5%) | $2.09 M(+109.3%) |
| Dec 2014 | $1.20 M(+264.0%) | $363.00 K(+11.7%) | $998.20 K(+29.1%) |
| Sep 2014 | - | $325.00 K(+58.4%) | $773.20 K(+49.2%) |
| Jun 2014 | - | $205.20 K(+95.4%) | $518.30 K(+46.8%) |
| Mar 2014 | - | $105.00 K(-23.9%) | $353.10 K(+9.0%) |
| Dec 2013 | $329.90 K(+27.8%) | $138.00 K(+96.9%) | $323.90 K(+31.1%) |
| Sep 2013 | - | $70.10 K(+75.3%) | $247.10 K(+2.6%) |
| Jun 2013 | - | $40.00 K(-47.2%) | $240.80 K(-9.9%) |
| Mar 2013 | - | $75.80 K(+23.9%) | $267.40 K(+3.6%) |
| Dec 2012 | $258.10 K(+1.7%) | $61.20 K(-4.1%) | $258.20 K(+31.1%) |
| Sep 2012 | - | $63.80 K(-4.2%) | $197.00 K(+47.9%) |
| Jun 2012 | - | $66.60 K(0.0%) | $133.20 K(+100.0%) |
| Mar 2012 | - | $66.60 K | $66.60 K |
| Dec 2011 | $253.70 K | - | - |
FAQ
- What is Panbela Therapeutics annual SGA?
- What is the all time high annual SGA for Panbela Therapeutics?
- What is Panbela Therapeutics annual SGA year-on-year change?
- What is Panbela Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly SGA year-on-year change?
- What is Panbela Therapeutics TTM SGA?
- What is the all time high TTM SGA for Panbela Therapeutics?
- What is Panbela Therapeutics TTM SGA year-on-year change?
What is Panbela Therapeutics annual SGA?
The current annual SGA of PBLA is $5.03 M
What is the all time high annual SGA for Panbela Therapeutics?
Panbela Therapeutics all-time high annual SGA is $6.04 M
What is Panbela Therapeutics annual SGA year-on-year change?
Over the past year, PBLA annual SGA has changed by -$1.01 M (-16.73%)
What is Panbela Therapeutics quarterly SGA?
The current quarterly SGA of PBLA is $1.11 M
What is the all time high quarterly SGA for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly SGA is $1.80 M
What is Panbela Therapeutics quarterly SGA year-on-year change?
Over the past year, PBLA quarterly SGA has changed by +$182.00 K (+19.55%)
What is Panbela Therapeutics TTM SGA?
The current TTM SGA of PBLA is -$544.81 M
What is the all time high TTM SGA for Panbela Therapeutics?
Panbela Therapeutics all-time high TTM SGA is -$13.67 M
What is Panbela Therapeutics TTM SGA year-on-year change?
Over the past year, PBLA TTM SGA has changed by -$549.84 M (-10924.70%)